VAERS reports by lot

Novartis Vaccines Meningococcal lot 59M3M: VAERS reports

22 VAERS reports list lot 59M3M as a Novartis Vaccines Meningococcal vaccine, received between 2022-07-30 and 2024-04-01. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
22
Reports
0%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Cardiac / Cardiovascular629%
Injection-site / Local reaction419%
Thrombotic / Hematological314%
Musculoskeletal210%
General / Systemic (non-local)210%
Neurological15%
Respiratory15%
Gastrointestinal15%
Dermatological (non-injection-site)15%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas5
Michigan4
Tennessee1
Colorado1
Virginia1
New York1
Indiana1
California1
North Carolina1
Louisiana1
Illinois1
Massachusetts1

Reports by month received

2022-071
2022-083
2022-092
2022-124
2023-011
2023-034
2023-043
2023-053
2024-041

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.